Paper Details

  1. Home
  2. Paper Details

Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

Author: , AsensiVíctor, BarriosAna, ClotetBonaventura, DomingoPere, EstradaVicente, LabargaPablo, MoralesDolores, NegredoEugenia, SantosJesús, SorianoVincent

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

A study compared the effectiveness of switching to a simpler antiretroviral regimen (tenofovir, didanosine, and efavirenz) versus remaining on the same regimen in HIV-1-infected patients. The simpler regimen was as effective as the original regimen in suppressing HIV-1 RNA when low doses of didanosine were used. However, the simpler regimen was associated with lower CD4+ cell counts, particularly when higher doses of didanosine were used.
Paper Details　
Original Abstract of the Article :
BACKGROUND: High pill burden and side effects often impact on the long-term success of highly active antiretroviral therapy (HAART), which has led clinicians to search for more convenient regimens. PATIENTS AND METHODS: A prospective, multicentre, open, comparative study in which HIV-1-infected pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/16312178

データ提供：米国国立医学図書館（NLM）

Simplifying HIV Treatment: A New Era of Convenience and Efficacy

The field of infectious diseases is constantly evolving, seeking to improve the treatment of HIV infection. This study investigates the feasibility of simplifying HIV treatment regimens, using a once-daily combination of didanosine, tenofovir, and efavirenz. The study aimed to assess the safety and efficacy of this simplified regimen in patients with viral suppression on more complex antiretroviral therapy.

A Simpler Approach: Balancing Convenience and Efficacy

The study findings suggest that simplifying HIV treatment regimens to a once-daily combination of didanosine, tenofovir, and efavirenz can achieve similar virological suppression rates compared to more complex regimens. This research highlights the potential for simplifying HIV treatment without compromising effectiveness, making it easier for patients to adhere to their medication schedules.

Living with HIV: Managing Treatment and Maintaining Health

If you are living with HIV, it's essential to work closely with your doctor to develop a treatment plan that best meets your individual needs. Simplifying treatment regimens can improve adherence and make it easier to manage your condition. By actively engaging in your healthcare journey and maintaining a healthy lifestyle, you can manage HIV effectively and live a fulfilling life.

Dr.Camel's Conclusion

Imagine a long desert trek, where navigating a complex path with multiple medications can be challenging. This research offers a shortcut, a simpler path towards managing HIV infection. It's like finding a hidden oasis where a single dose of medication can provide relief and sustenance, making the journey smoother and more manageable.

Date :
  1. Date Completed 2006-08-21
  2. Date Revised 2022-03-11
Further Info :

Pubmed ID

16312178

DOI: Digital Object Identifier

16312178

Related Literature

Article Analysis
・Side Effects of didanosine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.